These findings are consistent with concurrent reductions in TG, LDL-C, and HDL-C in LoF carriers, suggesting an epidemiologically coherent link between ANGPTL3’s multi-lipoprotein effects and reduced ASCVD risk (66). The gene discussed is ANGPTL3; the disease is atherosclerosis.